AU2021309364A1 - Polymorphs of a hydrochloride salt of PN6047 - Google Patents

Polymorphs of a hydrochloride salt of PN6047 Download PDF

Info

Publication number
AU2021309364A1
AU2021309364A1 AU2021309364A AU2021309364A AU2021309364A1 AU 2021309364 A1 AU2021309364 A1 AU 2021309364A1 AU 2021309364 A AU2021309364 A AU 2021309364A AU 2021309364 A AU2021309364 A AU 2021309364A AU 2021309364 A1 AU2021309364 A1 AU 2021309364A1
Authority
AU
Australia
Prior art keywords
salt
crystalline
pain
radiation
xrpd pattern
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021309364A
Other languages
English (en)
Other versions
AU2021309364A8 (en
Inventor
Hans G. Nilsson
Ingemar Starke
Bengt Von Mentzer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PharmNovo AB
Original Assignee
PharmNovo AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PharmNovo AB filed Critical PharmNovo AB
Publication of AU2021309364A1 publication Critical patent/AU2021309364A1/en
Publication of AU2021309364A8 publication Critical patent/AU2021309364A8/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2021309364A 2020-07-17 2021-07-12 Polymorphs of a hydrochloride salt of PN6047 Pending AU2021309364A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE2050910 2020-07-17
SE2050910-5 2020-07-17
PCT/EP2021/069340 WO2022013153A1 (en) 2020-07-17 2021-07-12 Polymorphs of a hydrochloride salt of pn6047

Publications (2)

Publication Number Publication Date
AU2021309364A1 true AU2021309364A1 (en) 2023-02-16
AU2021309364A8 AU2021309364A8 (en) 2023-03-16

Family

ID=77168220

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021309364A Pending AU2021309364A1 (en) 2020-07-17 2021-07-12 Polymorphs of a hydrochloride salt of PN6047

Country Status (7)

Country Link
US (1) US20230174525A1 (https=)
EP (1) EP4182312A1 (https=)
JP (2) JP2023533874A (https=)
CN (1) CN116171277B (https=)
AU (1) AU2021309364A1 (https=)
CA (1) CA3185973A1 (https=)
WO (1) WO2022013153A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103313D0 (sv) * 2001-10-03 2001-10-03 Astrazeneca Ab Novel compounds
US20110207745A1 (en) * 2009-11-25 2011-08-25 Astrazeneca Ab Solid forms of 4--n,n-diethylbenzamide, compositions thereof, and uses therewith
CA2970256C (en) * 2014-12-19 2022-03-29 Pharmnovo Ab Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists

Also Published As

Publication number Publication date
JP2023533874A (ja) 2023-08-04
CA3185973A1 (en) 2022-01-20
CN116171277B (zh) 2026-03-06
CN116171277A (zh) 2023-05-26
JP2026016435A (ja) 2026-02-03
EP4182312A1 (en) 2023-05-24
US20230174525A1 (en) 2023-06-08
AU2021309364A8 (en) 2023-03-16
WO2022013153A1 (en) 2022-01-20

Similar Documents

Publication Publication Date Title
CN113015521B (zh) 用于口服的包含氨基嘧啶衍生物或其盐的药物组合物
US20250019363A1 (en) Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide hemisuccinate, and preparation of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide acetate
US12365680B2 (en) Polymorphs of the hydrochloride salt of linaprazan glurate
US20220002297A1 (en) Polymorphs of x842
US20080234323A1 (en) Amorphous and Three Crystalline Forms of Rimonabant Hydrochloride
JP2024539726A (ja) Ｎ－（（１ｒ，３ｓ）－３－（４－アセチルピペラジン－１－イル）シクロヘキシル）－４－フルオロ－７－メチル－１ｈ－インドール－２－カルボキサミドの結晶形態
JP2018515566A (ja) 医薬組成物
US10377725B2 (en) Phenyl amino pyrimidine compound or polymorph of salt thereof
US20230174525A1 (en) Polymorphs of a hydrochloride salt of pn6047
WO2024149834A1 (en) Polymorphs of the hydrobromide salt of linaprazan glurate
WO2023079093A1 (en) Polymorphs of the mesylate salt of linaprazan glurate
HK40092799A (zh) Pn6047盐酸盐的多晶型物
EP3781568A1 (en) Form of ponatinib
EP4649078A1 (en) Polymorphs of the maleic acid salt of linaprazan glurate
EP4103546A1 (en) Polymorphs of elafibranor
CN121941687A (zh) 一种丙烯酰胺类化合物的晶型vi及其制备方法和用途
RU2024103096A (ru) Нитрозаминовая примесь, фармацевтическая композиция варениклина, способная снижать образование нитрозаминовых примесей, и ее приготовление и применение

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 57 , NO 6 , PAGE(S) 940 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME PHARMNOVO AB, APPLICATION NO. 2021309364, UNDER INID (72) ADD CO-INVENTOR NILSSON, HANS G.